chr12-9997256-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016509.4(CLEC1B):c.187C>A(p.Gln63Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,459,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016509.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLEC1B | NM_016509.4 | c.187C>A | p.Gln63Lys | missense_variant | 3/6 | ENST00000298527.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLEC1B | ENST00000298527.11 | c.187C>A | p.Gln63Lys | missense_variant | 3/6 | 1 | NM_016509.4 | P1 | |
CLEC1B | ENST00000348658.4 | c.88C>A | p.Gln30Lys | missense_variant | 2/5 | 1 | |||
CLEC1B | ENST00000428126.6 | c.88C>A | p.Gln30Lys | missense_variant | 4/7 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 249164Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135176
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1459862Hom.: 0 Cov.: 30 AF XY: 0.0000275 AC XY: 20AN XY: 726362
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2022 | The c.187C>A (p.Q63K) alteration is located in exon 3 (coding exon 3) of the CLEC1B gene. This alteration results from a C to A substitution at nucleotide position 187, causing the glutamine (Q) at amino acid position 63 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at